DNLI Denali Therapeutics Inc.

Fundamentals / CIK 0001714899 / USD

Denali Therapeutics Inc. reported $0 in revenue and a net loss of $314.4M for the fiscal year ended December 31, 2025.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open DNLI in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$384.9M$192.5M$0-$507.8MFY 2016 Revenue: $0FY 2016 Net Income: -$86.65M2016FY 2017 Revenue: $0FY 2017 Net Income: -$88.19M2017FY 2018 Revenue: $129.2MFY 2018 Net Income: -$36.24M2018FY 2019 Revenue: $26.68MFY 2019 Net Income: -$197.6M2019FY 2020 Revenue: $335.7MFY 2020 Net Income: $71.14M2020FY 2021 Revenue: $48.66MFY 2021 Net Income: -$290.6M2021FY 2022 Revenue: $108.5MFY 2022 Net Income: -$326.0M2022FY 2023 Revenue: $330.5MFY 2023 Net Income: -$145.2M2023FY 2024 Revenue: $0FY 2024 Net Income: -$422.8M2024FY 2025 Revenue: $0FY 2025 Net Income: -$512.5M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $0 $0 $330.5M $108.5M $48.66M $335.7M $26.68M $129.2M $0 $0
Research & Development $418.8M $396.4M $423.9M $358.7M $265.4M $212.6M $193.4M $143.2M $74.46M $75.70M
Total Operating Expenses $555.3M $501.9M $527.2M $449.2M $344.4M $272.9M $239.9M $175.5M $90.14M $87.43M
Operating Income -$555.3M -$487.3M -$196.7M -$340.7M -$295.8M $62.72M -$213.2M -$46.37M -$90.14M -$87.43M
EBITDA -$544.2M -$479.5M -$180.0M -$330.4M -$287.2M $71.25M -$205.2M -$38.96M -$87.06M -$85.96M
Income Tax Expense $102K $68K $30K $21K -$575K $823K -$351K $0 $0 --
Net Income -$512.5M -$422.8M -$145.2M -$326.0M -$290.6M $71.14M -$197.6M -$36.24M -$88.19M -$86.65M
Basic EPS -$2.97 -$2.57 -$1.06 -$2.60 -$2.39 $0.65 -$2.07 -$0.39 -$5.89 -$13.49
Diluted EPS -$2.97 -$2.57 -$1.06 -$2.60 -$2.39 $0.63 -$2.07 -$0.39 -$5.89 -$13.49
Basic Shares Outstanding 172.6M 164.5M 137.4M 125.5M 121.5M 109.0M 95.6M 92.6M 15.0M 6.4M
Diluted Shares Outstanding 172.6M 164.5M 137.4M 125.5M 121.5M 112.7M 95.6M 92.6M 15.0M 6.4M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $17.78M $3.60M -- -- $0 $0 -- $0
Cost of Revenue $192K $93K -- -- $0 $0 -- --
Gross Profit $17.59M $3.51M -- -- $0 $0 -- --
Research & Development $106.1M $97.02M $103.8M $97.91M $102.0M $102.7M $116.2M $99.79M
Selling, General & Admin $37.48M $36.28M -- -- $35.48M $32.27M -- --
Total Operating Expenses -- -- $137.4M $137.4M $137.4M $135.0M $145.6M $129.8M
Operating Income -$126.8M -$130.5M -$137.4M -$137.4M -$137.4M -$135.0M -$145.6M -$129.8M
EBITDA -$123.2M -$127.0M -$134.5M -$134.5M -$134.5M -$131.9M -$143.3M -$128.0M
Net Income $70.13M -$127.6M -$128.4M -$128.5M -$126.9M -$124.1M -$133.0M -$114.8M
Basic EPS $0.37 -$0.68 -$0.69 -- -$0.74 -$0.72 -$0.78 --
Diluted EPS $0.37 -$0.68 -$0.69 -- -$0.74 -$0.72 -$0.78 --
Basic Shares Outstanding 188.4M 187.3M 186.6M -- 172.4M 171.4M 171.2M --
Diluted Shares Outstanding 192.1M 187.3M 186.6M -- 172.4M 171.4M 171.2M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $205.3M $175.0M $127.1M $218.0M $293.5M $507.1M $79.45M $77.12M $218.4M
Short-Term Investments $662.6M $657.4M $907.4M $1.12B $571.9M $962.6M $335.9M $387.2M $187.9M
Cash & Short-Term Investments $867.9M $832.3M $1.03B $1.34B $865.4M $1.47B $415.4M $464.3M $406.2M
Accounts Receivable, Net $0 -- -- -- -- $8.59M -- -- --
Inventory $0 -- -- -- -- -- -- -- --
Total Current Assets $900.7M $864.4M $1.06B $1.37B $897.2M $1.50B $430.0M $480.8M $409.6M
Property, Plant & Equipment, Net $52.40M $55.24M $45.59M $44.09M $38.87M $40.85M $46.73M $25.16M $14.92M
Intangible Assets $0 -- -- -- -- -- -- -- --
Long-Term Investments $98.32M $359.4M $0 $0 $425.4M $32.70M $39.89M $147.9M $60.75M
Other Non-Current Assets $25.94M $24.74M $18.14M $13.40M $11.87M $2.46M $2.66M $8.11M $1.44M
Total Non-Current Assets $244.2M $509.7M $89.78M $87.92M $506.9M $108.6M $123.2M $181.1M $77.11M
Total Assets $1.14B $1.37B $1.15B $1.46B $1.40B $1.60B $553.2M $662.0M $486.7M
Accounts Payable $505K $11.14M $9.48M $2.79M $4.78M $1.07M $2.59M $1.89M $2.72M
Deferred Revenue (Current) -- -- $0 $290.1M $27.91M $19.91M $18.74M $11.43M $0
Other Current Liabilities -- -- $0 $4.39M $53.16M $47.15M $24.02M $19.47M $63K
Total Current Liabilities $98.35M $102.2M $77.98M $363.9M $378.2M $71.70M $45.34M $32.79M $14.16M
Deferred Revenue (Non-Current) -- -- $0 $479K $3.40M $23.32M $43.75M $57.35M $0
Other Non-Current Liabilities -- -- $0 $379K $379K $701K $379K $471K $467K
Total Non-Current Liabilities $32.74M $42.29M $44.98M $53.89M $63.63M $382.1M $113.0M $82.35M $6.76M
Total Liabilities $131.1M $144.5M $123.0M $417.8M $441.9M $453.7M $158.3M $115.1M $20.93M
Total Debt (incl. Leases) $42.29M $54.32M $52.24M $60.35M $64.01M $68.86M $72.53M -- --
Common Stock -- -- $1.71M $1.69M $1.55M $1.53M $1.29M $1.27M $1.20M
Retained Earnings -$2.05B -$1.54B -$1.12B -$971.0M -$645.0M -$354.4M -$425.6M -$227.9M -$191.7M
Accumulated Other Comp. Income $682K $2.02M $643K -$6.89M -$2.50M -$245K $350K -$649K -$368K
Total Stockholders' Equity $1.01B $1.23B $1.03B $1.04B $962.3M $1.15B $394.9M $546.8M $465.8M
Total Equity $1.01B $1.23B $1.03B $1.04B $962.3M $1.15B $394.9M $546.8M $465.8M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $102.9M $201.5M $387.6M $205.3M $90.96M $141.2M $56.95M $175.0M
Short-Term Investments $413.3M $508.9M $600.1M $662.6M $757.2M $757.7M $761.0M $657.4M
Cash & Short-Term Investments $516.2M $710.5M $987.7M $867.9M $848.2M $899.0M $817.9M $832.3M
Accounts Receivable, Net $18.88M $3.93M -- $0 -- -- -- --
Inventory $26.27M $4.14M -- $0 -- -- -- --
Total Current Assets $591.7M $753.9M $1.02B $900.7M $882.6M $934.7M $878.6M $864.4M
Property, Plant & Equipment, Net $47.91M $49.93M $51.73M $52.40M $53.73M $58.72M $57.77M $55.24M
Intangible Assets $34.50M $35.25M $36.00M $0 -- -- -- --
Long-Term Investments $491.4M $229.5M $63.78M $98.32M $24.70M $78.46M $235.8M $359.4M
Other Non-Current Assets $29.15M $25.82M $26.22M $25.94M $25.11M $22.97M $26.93M $24.74M
Total Non-Current Assets $664.3M $404.0M $243.3M $244.2M $173.0M $231.5M $392.7M $509.7M
Total Assets $1.26B $1.16B $1.27B $1.14B $1.06B $1.17B $1.27B $1.37B
Accounts Payable $13.70M $11.81M $40.38M $505K $6.75M $10.84M $8.46M $11.14M
Total Current Liabilities $95.26M $90.08M $110.2M $98.35M $90.15M $91.06M $91.88M $102.2M
Total Non-Current Liabilities $234.4M $232.7M $229.8M $32.74M $39.28M $48.13M $56.78M $42.29M
Total Liabilities $329.6M $322.8M $339.9M $131.1M $129.4M $139.2M $148.7M $144.5M
Total Debt (incl. Leases) $35.24M $37.69M $40.05M $42.29M $44.48M $47.97M $51.57M $54.32M
Retained Earnings -$2.24B -$2.31B -$2.18B -$2.05B -$1.92B -$1.80B -$1.67B -$1.54B
Accumulated Other Comp. Income -$6.36M -$1.97M -$682K $682K $1.10M $939K $2.04M $2.02M
Total Stockholders' Equity $926.4M $835.2M $926.1M $1.01B $926.2M $1.03B $1.12B $1.23B
Total Equity $926.4M $835.2M $926.1M $1.01B $926.2M $1.03B $1.12B $1.23B

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$512.5M -$422.8M -$145.2M -$326.0M -$290.6M $71.14M -$197.6M -$36.24M -$88.19M -$86.65M
Depreciation & Amortization $11.18M $7.79M $16.73M $10.38M $8.59M $8.53M $7.99M $7.42M $3.08M $1.47M
Stock-Based Compensation $99.63M $102.9M $108.1M $99.85M $85.25M $50.35M $38.38M $18.79M $4.41M $2.95M
Change in Payables -$7.52M $1.44M $2.43M $2.27M $3.71M -$1.62M $1.03M -$526K $207K $161K
Operating Cash Flow -$412.6M -$347.7M -$358.0M -$244.7M -$211.4M $416.2M -$151.6M $50.12M -$76.64M -$71.91M
Capital Expenditure -$9.50M -$15.91M -$12.94M -$17.83M -$8.50M -$3.10M -$17.92M -$3.39M -$2.88M -$6.13M
Free Cash Flow -$422.1M -$363.6M -$370.9M -$262.5M -$219.9M $413.1M -$169.5M $46.72M -$79.51M -$78.04M
Purchases of Investments -$441.3M -$1.23B -$1.81B -$1.12B -$1.42B -$1.29B -$369.7M -$557.9M -$179.8M -$226.4M
Investing Cash Flow $255.3M -$88.76M $249.3M -$141.4M -$21.63M -$623.2M $147.7M -$287.4M -$41.17M -$219.0M
Common Stock Issued -- $0 $0 $296.2M $0 $193.9M $0 $0 $265.6M $0
Financing Cash Flow $189.2M $484.3M $17.82M $310.7M $19.35M $634.7M $6.19M $97.02M $296.3M $300.5M
Net Change in Cash $31.90M $47.85M -$90.86M -$75.43M -$213.7M $427.7M $2.33M -$140.3M $178.5M $9.56M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income $70.13M -$127.6M -$128.4M -$128.5M -$126.9M -$124.1M -$133.0M -$114.8M
Depreciation & Amortization $3.58M $3.57M $2.85M $2.87M $2.95M $3.04M $2.33M $1.85M
Stock-Based Compensation $22.86M $22.91M $23.09M $23.95M $25.14M $25.39M $25.16M $25.08M
Change in Payables $8.90M $227K $3.88M -$3.41M -$4.07M $2.60M -$2.64M $1.29M
Operating Cash Flow -$117.4M -$97.00M -$131.2M -$98.54M -$107.3M -$75.30M -$131.5M -$83.72M
Capital Expenditure -$1.01M -$805K -$2.47M -$1.52M $1.38M -$4.28M -$5.08M -$5.09M
Free Cash Flow -$118.5M -$97.81M -$133.7M -$100.1M -$105.9M -$79.58M -$136.5M -$88.81M
Purchases of Investments -$355.2M -$271.5M -$123.1M -$252.7M -$50.63M $0 -$137.9M -$173.7M
Investing Cash Flow $16.19M -$104.1M $94.46M $20.77M $57.83M $157.9M $18.75M $172.2M
Common Stock Issued $0 $0 $12.37M -- $0 $0 $0 -$499.3M
Financing Cash Flow $2.59M $14.98M $219.0M $192.1M -$778K $1.62M -$3.76M -$4.17M
Net Change in Cash -$98.66M -$186.1M $182.3M $114.4M -$50.24M $84.26M -$116.5M $84.32M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Operating Margin -- -- -59.5% -314.2% -607.8% 18.7% -799.1% -35.9% -- --
Net Profit Margin -- -- -43.9% -300.6% -597.2% 21.2% -740.7% -28.1% -- --
Return on Equity (ROE) -50.6% -34.4% -14.1% -31.3% -30.2% 6.2% -50.0% -6.6% -18.9% --
Return on Assets (ROA) -44.8% -30.8% -12.6% -22.3% -20.7% 4.4% -35.7% -5.5% -18.1% --
Current Ratio 9.16x 8.46x 13.65x 3.77x 2.37x 20.86x 9.48x 14.67x 28.92x --
Quick Ratio 9.16x 8.14x 13.27x 3.67x 2.29x 20.62x 9.16x 14.16x 28.68x --
Debt to Equity 0.04x 0.04x 0.05x 0.06x 0.07x 0.06x 0.18x -- -- --
Revenue Growth (YoY) -- -100.0% +204.7% +122.9% -85.5% +1158.2% -79.3% -- -- --
Operating Income Growth (YoY) -- -- -- -- -571.6% -- -- -- -- --
Net Income Growth (YoY) -- -- -- -- -508.5% -- -- -- -- --
EPS Growth (YoY) -- -- -- -- -467.7% -- -- -- -- --
Operating Cash Flow Growth (YoY) -- -- -- -- -150.8% -- -402.5% -- -- --
Free Cash Flow Growth (YoY) -- -- -- -- -153.2% -- -462.8% -- -- --
5Y Revenue / Share Growth -100.0% -100.0% +72.5% -- -- -- -- -- -- --
5Y Net Income / Share Growth -554.8% -- -- -- -- -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -33.9% -61.2% -54.9% -50.6% -53.8% -46.6% -40.4% -34.4%
Return on Assets (ROA) -25.0% -44.2% -40.1% -44.8% -47.2% -41.1% -35.7% -30.8%
Current Ratio 6.21x 8.37x 9.28x 9.16x 9.79x 10.27x 9.56x 8.46x
Quick Ratio 5.94x 8.32x 8.97x 9.16x 9.41x 9.87x 8.90x 8.14x
Debt to Equity 0.04x 0.05x 0.04x 0.04x 0.05x 0.05x 0.05x 0.04x
Source: SEC EDGAR CompanyFacts (CIK 0001714899) · from December 31, 2016 Data through September 30, 2026 · synced Nov 20, 2026, 05:19 UTC · Open in terminal